Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Open-Label, Randomized, Phase 3 Study of Coformulated Favezelimab and Pembrolizumab Versus Chemotherapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Refractory to Anti-PD-1 Therapy: Keyform-008

David Lavie, John Timmerman, Ramón García-Sanz, Won Seog Kim, Tae Min Kim, Abraham Avigdor, Daan Dierickx, Deepa Jagadeesh, Daniel L. Molin, Muhit Ozcan, Omur Gokmen Sevindik, Hayder Saeed, Yulia Sidi, Pallavi Pillai, Patricia Marinello, Alex F. Herrera

Blood (2023) 142 (Supplement 1): 3082.

https://doi.org/10.1182/blood-2023-182119

Published: 2023

Journal Articles

Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma

Marlies Vanden Bempt, Koen Debackere, Sofie Demeyer, Quentin Van Thillo, Nienke Meeuws, Cristina Prieto, Sarah Provost, Nicole Mentens, Kris Jacobs, Olga Gielen, David Nittner, Seishi Ogawa, Keisuke Kataoka, Carlos Graux, Thomas Tousseyn, Jan Cools, Daan Dierickx

Blood (2022) 140 (23): 2463–2476.

https://doi.org/10.1182/blood.2022016428

Published: 2022

Includes: Supplemental data

Journal Articles

Consolidation Improves Survival in Primary Central Nervous System Lymphoma without Preference for Type of High-Dose Methotrexate-Based Induction Treatment Regimen

Blood (2022) 140 (Supplement 1): 369–371.

https://doi.org/10.1182/blood-2022-163244

Published: 2022

Journal Articles

New and Updated Results from a Multicenter, Open-Label, Global Phase 3 Study of Tabelecleucel (Tab-cel) for Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV + PTLD) Following Allogeneic Hematopoietic Cell (HCT) or Solid Organ Transplant (SOT) after Failure of Rituximab or Rituximab and Chemotherapy (ALLELE)

Kris Michael Mahadeo, Robert A. Baiocchi, Amer Beitinjaneh, Sridhar Chaganti, Sylvain Choquet, Daan Dierickx, Rajani Dinavahi, Laurence Gamelin, Armin Ghobadi, Norma Guzman-Becerra, Manher Joshi, Aditi Mehta, Sarah Nikiforow, Ran Reshef, Wei Ye, Susan Prockop

Blood (2022) 140 (Supplement 1): 10374–10376.

https://doi.org/10.1182/blood-2022-157766

Published: 2022

Journal Articles

Clinical Outcomes of Solid Organ Transplant Patients with Epstein-Barr Virus-Driven (EBV + ) Post-Transplant Lymphoproliferative Disorder (PTLD) Who Fail Rituximab Plus Chemotherapy: A Multinational, Retrospective Chart Review Study

Vikas Dharnidharka, Dhanalakshmi Thirumalai, Ulrich Jaeger, Weizhi Zhao, Daan Dierickx, Pengcheng Xun, Periana Minga, Ahmed Sawas, Natalia Sadetsky, Paul Chauvet, Erin Sundaram, Arie Barlev, Heiner Zimmermann, Ralf Ulrich Trappe

Blood (2021) 138 (Supplement 1): 2528.

https://doi.org/10.1182/blood-2021-147307

Published: 2021

Journal Articles

Clinical Outcomes of Patients with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Hematopoietic Stem Cell Transplantation Who Fail Rituximab: A Multinational, Retrospective Chart Review Study

Jaime Sanz, Jan Storek, Gérard Socié, Dhanalakshmi Thirumalai, Norma Guzman-Becerra, Pengcheng Xun, Deepali Kumar, Natalia Sadetsky, Daan Dierickx, John Reitan, Arie Barlev, Mohamad Mohty

Blood (2021) 138 (Supplement 1): 1454.

https://doi.org/10.1182/blood-2021-147296

Published: 2021

Journal Articles

FER and FES tyrosine kinase fusions in follicular T-cell lymphoma

Koen Debackere, Jo-Anne van der Krogt, Thomas Tousseyn, Julio Antonio Finalet Ferreiro, Katrien Van Roosbroeck, Lukas Marcelis, Carlos Graux, Daan Dierickx, Geneviève Ameye, Peter Vandenberghe, Lucienne Michaux, Jan Cools, Iwona Wlodarska

Blood (2020) 135 (8): 584–588.

https://doi.org/10.1182/blood.2019002401

Published: 2020

Includes: Supplemental data

Journal Articles

Kinetics of Myeloid-Derived Suppressor Cells during Stem Cell Mobilization and Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma and Lymphoma Patients

Anika Betsch, MSc, Omer Rutgeerts, MSc, Sabine Fevery, MD PhD, Ben Sprangers, MD PhD, Daan Dierickx, MD PhD, Marielle Beckers, MD PhD

Blood (2018) 132 (Supplement 1): 2065.

https://doi.org/10.1182/blood-2018-99-118094

Published: 2018

Journal Articles

Successful Treatment of MYC rearrangement Positive Large B Cell Lymphoma Patients with R-CHOP21 Plus Lenalidomide: Results of a Multicenter Phase II HOVON Trial

Martine E.D. Chamuleau, MD, Marcel Nijland, MD, Josée M Zijlstra, MD, Rogier Mous, MD PhD, P.J. Lugtenburg, Daan Dierickx, MD PhD, Gustaaf van Imhoff, MD PhD, Joost Vermaat, MD PhD, Katerina Bakunina, Erik W.A. Marijt, MD, Otto Visser, MDPhD, Caroline Mandigers, MD, Yavuz Bilgin, MDPhD, Coreline Burggraaff, Otto Hoekstra, MDPhD, Daphne de Jong, Prof Dr, Marie José Kersten, MD

Blood (2018) 132 (Supplement 1): 786.

https://doi.org/10.1182/blood-2018-99-110240

Published: 2018

Journal Articles

Use of Bortezomib-Containing Regimens in the Frontline Treatment of Patients with Plasmablastic Lymphoma: A Multicenter Retrospective Analysis

Thomas Guerrero, MD, Michele Bibas, MD, Franco Baldini, MD, Guillaume Cartron, Kate Cwynarski, MD, Daan Dierickx, MD PhD, Frederick Lansigan, MD, Yevgeniy A Linnik, MD, Renzo Mogollon, MD, Jose Tomas Navarro, MD PhD, Slavisa Ninkovic, MBBS FRACP FRCPA, Adam J Olszewski, MD, John L. Reagan, MD, Emmanuelle Tchernonog, MD, Thomas Tousseyn, MD PhD, Jorge J. Castillo, MD

Blood (2017) 130 (Supplement 1): 1580.

https://doi.org/10.1182/blood.V130.Suppl_1.1580.1580

Published: 2017

Journal Articles

IGH -Mediated Translocations, Recurrent in Classic Hodgkin Lymphoma, Frequently Correlate with an Aggressive Behavior

Iwona Wlodarska, PhD, Daan Dierickx, MD PhD, Ursula Pluys, Kathleen Doms, Carlos Graux, MD PhD, Achiel Van Hoof, MD PhD, Peter Vandenberghe, MD PhD, Lucienne Michaux, MD PhD, Thomas Tousseyn

Blood (2016) 128 (22): 2922.

https://doi.org/10.1182/blood.V128.22.2922.2922

Published: 2016

Journal Articles

Response to Rituximab Induction Is a Predictive Biomarker in Post-Transplant Lymphoproliferative Disorder (PTLD) and Allows Successful Treatment Stratification in an International Phase II Trial Including 152 Patients

Blood (2015) 126 (23): 816.

https://doi.org/10.1182/blood.V126.23.816.816

Published: 2015

Journal Articles

How I treat posttransplant lymphoproliferative disorders

Daan Dierickx, Thomas Tousseyn, Olivier Gheysens

Blood (2015) 126 (20): 2274–2283.

https://doi.org/10.1182/blood-2015-05-615872

Published: 2015

Journal Articles

The role of rituximab in adults with warm antibody autoimmune hemolytic anemia

Daan Dierickx, Alain Kentos, André Delannoy

Blood (2015) 125 (21): 3223–3229.

https://doi.org/10.1182/blood-2015-01-588392

Published: 2015

Journal Articles

Non-Invasive Detection of Genomic Imbalances in Hodgkin/Reed-Sternberg Cells in Early and Advanced Stage Hodgkin Lymphoma By Sequencing of Circulating Cell-Free DNA

Peter Vandenberghe, MDPhD, Iwona Wlodarska, PhD, Thomas Tousseyn, MDPhD, Luc Dehaspe, PhD, Daan Dierickx, MDPhD, Magali Verheecke, MD, Anne Uyttebroeck, MDPhD, Oliver Bechter, MDPhD, Michel Delforge, MDPhD, Vincent Vandecaveye, MDPhD, Nathalie Brison, PhD, Gregor EG Verhoef, MDPhD, Eric Legius, MDPhD, Frederic Amant, MDPhD, Joris R Vermeesch, PhD

Blood (2014) 124 (21): LBA-4.

https://doi.org/10.1182/blood.V124.21.LBA-4.LBA-4

Published: 2014

Journal Articles

Involvement of FER and FES in the Pathogenesis of Follicular Variant of Peripheral T-Cell Lymphoma

Iwona Wlodarska, PhD, Jo-Anne van der Krogt, Msc, Katrien Van Roosbroeck, PhD, Julio Finalet Ferreiro, Msc, Thomas Tousseyn, MD PhD, Carlos Graux, MD PhD, Daan Dierickx, MD PhD, Peter Vandenberghe, MD PhD, Jan Cools, PhD

Blood (2014) 124 (21): 5194.

https://doi.org/10.1182/blood.V124.21.5194.5194

Published: 2014

Journal Articles

The Accuracy of PET in the Detection of Posttransplant Lymphoproliferative Disorder (PTLD)

Daan Dierickx, MD, Gregor Verhoef, Olivier Gheysens, MD, Thomas Tousseyn, MD PhD, Christiane De Wolf-Peeters, MD PhD, Iwona Wlodarska, PhD, Lieselot Brepoels, MD

Blood (2011) 118 (21): 2657.

https://doi.org/10.1182/blood.V118.21.2657.2657

Published: 2011

Journal Articles

Primary Central Nervous System (PCNS) Post-Transplant Lymphoproliferative Disease (PTLD): An International Report of 65 Cases in the Modern Era

Andrew M. Evens, DO, MSc, Sylvain Choquet, MD, Aimee Kroll, MS, Sonali M. Smith, MD, Véronique Leblond, MD, PhD, Rupali Roy, MD, Bruce Barton, PhD, Daan Dierickx, MD, David Schiff, MD, Thomas M. Habermann, MD, Ralf Trappe, MD, PhD

Blood (2011) 118 (21): 879.

https://doi.org/10.1182/blood.V118.21.879.879

Published: 2011

Journal Articles

T(X;14)(p11.4;q32.33) Is Recurrent In Marginal Zone Lymphoma and Upregulates GPR34

Iwona Wlodarska, PhD, Julio Finalet Ferreiro, M Sc, Thomas Tousseyn, MD PhD, Helena Urbankova, PhD, Lucienne Michaux, MD PhD, Laurence de Leval, MD PhD, Daan Dierickx, MD, Pascal Wolter, MD PhD, Xavier Sagaert, MD PhD, Peter Vandenberghe, MD, PhD, Christiane De Wolf-Peeters, MD PhD, Mathijs Baens, PhD

Blood (2011) 118 (21): 1349.

https://doi.org/10.1182/blood.V118.21.1349.1349

Published: 2011

Journal Articles

Sequential Treatment with Rituximab and CHOP Chemotherapy in B-Cell PTLD - Moving Forward to a First Standard of Care: Results From a Prospective International Multicenter Trial.

Blood (2009) 114 (22): 100.

https://doi.org/10.1182/blood.V114.22.100.100

Published: 2009

NARROW

Open-Label, Randomized, Phase 3 Study of Coformulated Favezelimab and Pembrolizumab Versus Chemotherapy in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Refractory to Anti-PD-1 Therapy: Keyform-008

Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma

Consolidation Improves Survival in Primary Central Nervous System Lymphoma without Preference for Type of High-Dose Methotrexate-Based Induction Treatment Regimen

Clinical Outcomes of Solid Organ Transplant Patients with Epstein-Barr Virus-Driven (EBV + ) Post-Transplant Lymphoproliferative Disorder (PTLD) Who Fail Rituximab Plus Chemotherapy: A Multinational, Retrospective Chart Review Study

Clinical Outcomes of Patients with Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease Following Hematopoietic Stem Cell Transplantation Who Fail Rituximab: A Multinational, Retrospective Chart Review Study

FER and FES tyrosine kinase fusions in follicular T-cell lymphoma

Kinetics of Myeloid-Derived Suppressor Cells during Stem Cell Mobilization and Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma and Lymphoma Patients

Successful Treatment of MYC rearrangement Positive Large B Cell Lymphoma Patients with R-CHOP21 Plus Lenalidomide: Results of a Multicenter Phase II HOVON Trial

Use of Bortezomib-Containing Regimens in the Frontline Treatment of Patients with Plasmablastic Lymphoma: A Multicenter Retrospective Analysis

IGH -Mediated Translocations, Recurrent in Classic Hodgkin Lymphoma, Frequently Correlate with an Aggressive Behavior

Response to Rituximab Induction Is a Predictive Biomarker in Post-Transplant Lymphoproliferative Disorder (PTLD) and Allows Successful Treatment Stratification in an International Phase II Trial Including 152 Patients

How I treat posttransplant lymphoproliferative disorders

The role of rituximab in adults with warm antibody autoimmune hemolytic anemia

Non-Invasive Detection of Genomic Imbalances in Hodgkin/Reed-Sternberg Cells in Early and Advanced Stage Hodgkin Lymphoma By Sequencing of Circulating Cell-Free DNA

Involvement of FER and FES in the Pathogenesis of Follicular Variant of Peripheral T-Cell Lymphoma

The Accuracy of PET in the Detection of Posttransplant Lymphoproliferative Disorder (PTLD)

Primary Central Nervous System (PCNS) Post-Transplant Lymphoproliferative Disease (PTLD): An International Report of 65 Cases in the Modern Era

T(X;14)(p11.4;q32.33) Is Recurrent In Marginal Zone Lymphoma and Upregulates GPR34

Sequential Treatment with Rituximab and CHOP Chemotherapy in B-Cell PTLD - Moving Forward to a First Standard of Care: Results From a Prospective International Multicenter Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only